(Q84637564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants (English)

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

15 June 2024

1 reference

Wendy Comisar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Peng Sun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Alisha Norcross

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sheng Bi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kalyan Ghosh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Naoto Uemera

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Elizabeth M. Migoya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

15 June 2024

Goutam C. Mistry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

15 June 2024

Julie A. Stone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

15 June 2024

Gregory A. Winchell

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

15 June 2024

Paul J. Deutsch

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

15 June 2024

John A. Wagner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

15 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20679501

15 June 2024

publication date

2 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 February 2020

http://www.jclinpharm.org/cgi/content/abstract/51/2/202

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20679501

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270010374853

15 June 2024

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010374853/fullpdf

15 June 2024

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

The Journal of Clinical Pharmacology

15 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

202-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

9 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species

15 June 2024

2

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

15 June 2024

3

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis

15 June 2024

4

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

15 June 2024

5

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Comparison of caspofungin and amphotericin B for invasive candidiasis

15 June 2024

6

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Caspofungin for the treatment of less common forms of invasive candidiasis

15 June 2024

7

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

15 June 2024

8

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

15 June 2024

9

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.

15 June 2024

11

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

15 June 2024

13

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Potential for interactions between caspofungin and nelfinavir or rifampin

15 June 2024

14

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

15 June 2024

15

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma

15 June 2024

16

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

15 June 2024

17

1 reference

https://api.crossref.org/works/10.1177/0091270010374853

15 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20679501%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference